Found: 21
Select item for more details and to access through your institution.
Outcomes of patients with large B‐cell lymphomas and progressive disease following CD19‐specific CAR T‐cell therapy.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 8, p. E209, doi. 10.1002/ajh.25505
- By:
- Publication type:
- Article
Single agents vs combination chemotherapy in relapsed and refractory peripheral T‐cell lymphoma: Results from the comprehensive oncology measures for peripheral T‐cell lymphoma treatment (COMPLETE) registry.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 6, p. 641, doi. 10.1002/ajh.25463
- By:
- Publication type:
- Article
Eligibility for CAR T‐cell therapy: An analysis of selection criteria and survival outcomes in chemorefractory DLBCL.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 4, p. E117, doi. 10.1002/ajh.25411
- By:
- Publication type:
- Article
Description and prognostic significance of the kinetics of minimal residual disease status in adults with acute lymphoblastic leukemia treated with HyperCVAD.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 4, p. 546, doi. 10.1002/ajh.25030
- By:
- Publication type:
- Article
Response assessment in lymphoma: Concordance between independent central review and local evaluation in a clinical trial setting.
- Published in:
- Clinical Trials, 2016, v. 13, n. 5, p. 545, doi. 10.1177/1740774516645338
- By:
- Publication type:
- Article
Outcomes for Relapsed and Refractory Peripheral T-Cell Lymphoma Patients after Front-Line Therapy from the COMPLETE Registry.
- Published in:
- Acta Haematologica, 2020, v. 143, n. 1, p. 40, doi. 10.1159/000500666
- By:
- Publication type:
- Article
Outcomes of Patients with Transformed Mycosis Fungoides: Analysis from a Prospective Multicenter US Cohort Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Outcomes of Patients With Therapy-Related MDS After Chemoimmunotherapy for Chronic Lymphocytic Leukemia Compared With Patients With De Novo MDS: A Single-Institution Experience.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Analysis of Peripheral T-cell Lymphoma Diagnostic Workup in the United States.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Clinical binding properties, internalization kinetics, and clinicopathologic activity of brentuximab vedotin: an antibody-drug conjugate for CD30-positive lymphoid neoplasms.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
A phase I study of pulse high-dose vorinostat (V) plus rituximab (R), ifosphamide, carboplatin, and etoposide ( ICE) in patients with relapsed lymphoma.
- Published in:
- British Journal of Haematology, 2013, v. 161, n. 2, p. 183, doi. 10.1111/bjh.12230
- By:
- Publication type:
- Article
Clofarabine with high dose cytarabine and granulocyte colony-stimulating factor (G-CSF) priming for relapsed and refractory acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2011, v. 155, n. 2, p. 182, doi. 10.1111/j.1365-2141.2011.08831.x
- By:
- Publication type:
- Article
Allogeneic haematopoietic cell transplantation after nonmyeloablative conditioning in patients with T-cell and natural killer-cell lymphomas.
- Published in:
- British Journal of Haematology, 2010, v. 150, n. 2, p. 170, doi. 10.1111/j.1365-2141.2010.08210.x
- By:
- Publication type:
- Article
Cerebrospinal fluid flow cytometry and risk of central nervous system relapse after hyperCVAD in adults with acute lymphoblastic leukemia.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 7, p. 1411, doi. 10.1002/cncr.34073
- By:
- Publication type:
- Article
A pilot study of weekly brentuximab vedotin in patients with CD30+ malignancies resistant to brentuximab vedotin every 3 weeks.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 1, p. 159, doi. 10.1111/bjh.15742
- By:
- Publication type:
- Article
Bendamustine with rituximab, etoposide and carboplatin (T(R)EC) in relapsed or refractory aggressive lymphoma: a prospective multicentre phase 1/2 clinical trial.
- Published in:
- British Journal of Haematology, 2018, v. 183, n. 4, p. 601, doi. 10.1111/bjh.15585
- By:
- Publication type:
- Article
A phase II study of cyclophosphamide, etoposide, vincristine and prednisone ( CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma ( PTCL): final results from the T- cell consortium trial.
- Published in:
- British Journal of Haematology, 2016, v. 172, n. 4, p. 535, doi. 10.1111/bjh.13855
- By:
- Publication type:
- Article
High-dose CD20-targeted radioimmunotherapy-based autologous transplantation improves outcomes for persistent mantle cell lymphoma.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 5, p. 788, doi. 10.1111/bjh.13773
- By:
- Publication type:
- Article
A prospective cohort study of patients with peripheral T-cell lymphoma in the United States.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma.
- Published in:
- 2017
- By:
- Publication type:
- clinical trial
Brentuximab vedotin administered to platinum-refractory, transplant-naïve Hodgkin lymphoma patients can increase the proportion achieving FDG PET negative status.
- Published in:
- 2015
- By:
- Publication type:
- journal article